Background: Tight glycemic control in the critically ill is known to reduce both the morbidity and the mortality.
Introduction
The subject of tight glycemic control in the critically ill is of great signifi cance. Studies have shown signifi cant reduction in mortality and morbidity with the use of intensive insulin therapy in the critically ill. This may be due to a reduction of systemic infl ammation, prevention of immune dysfunction, protection of the endothelium and of the mitochondrial ultrastructure and function. [1] In this scenario, it has become essential that all endocrinologists and intensivists have a clear understanding of the current guidelines for tight glycemic control in the critically ill. This questionnaire survey was conducted to assess the KAP of endocrinologists and intensivists about tight glycemic control in the critically ill.
Objectives
• To assess the KAP of endocrinologists and intensivists practicing in the Chennai city, about tight glycemic control in the critically ill.
• To see if there is a common consensus among the endocrinologists and among the intensivists on the various issues regarding tight glycemic control in the critically ill.
Materials and Methods
The issues relating to tight glycemic control in the critically ill were considered. Questions were prepared to address each of the following aspects.
• Clinical outcomes of maintaining tight glycemic control in the critically ill • Adverse events related to tight glycemic control in the critically ill • Target levels of glycemic control • Blood sugar monitoring in the critically ill • Insulin regimen for glycemic control in the critically ill A total of ten questions were asked to address all these issues; at the same time the number of questions was kept limited to avoid responder disinterest. These questionnaires were hand delivered to six endocrinologists and fi fty-two intensivists practicing in the city of Chennai to be answered and returned in a week's time. Endocrinologists were defi ned as physicians trained in the fi eld of endocrinology either in India or abroad and practicing active endocrinology in the outpatient and inpatient setting. Intensivists were defi ned as physicians, surgeons or anesthesiologists who were currently involved in taking care of critically ill patients in intensive care units. Some of the questionnaires were also answered by postgraduate students in training in the fi eld of intensive care. Diabetologists who were not endocrinologists were not included in the study. Among the endocrinologists, four were from large private hospitals and two were in private practice. Among the intensivists, fi fty belonged to large private hospitals and teaching hospitals and two belonged to small private hospitals.
Questions

Results
The results are tabulated in Tables 1-4 .
All those who were given the questionnaires responded. Some of the responders did not answer some questions. The percentage of responders who did not answer the questions was not large and so is unlikely to bring a signifi cant change in the results. For some of the questions some physicians had selected more than one response. This is also refl ected in the tables.
Majority of the responders (88%) did believe in tight glycemic control in the critically ill. The most popular reason for the belief was "Better outcomes from this hospitalization". A very small minority of the responders did not believe in tight glycemic control and the reason for the same being incidence of hypoglycemia. A little over half of the responders (53.4%) agreed on the cut off value of 110 mg/dL as followed in the Greet Van Den Berghe study. The next most popular cut off was 150 mg/dL. Most of the responders (70.7%) voted for the glucometer as the method of monitoring the sugar levels. There was considerable variation in the choices for frequency of the monitoring tests.
As far as the methods used for glycemic control were concerned, insulin infusion was the most popular choice and human regular insulin was the type of insulin voted for. There was considerable variation in the method adopted while transferring the patient from the critical care unit to the fl oors.
Hypoglycemia was opted as the important complication during tight glycemic control by 58.6% of the responders. Standing orders for insulin dosage was the more popular method among the endocrinologists and the intensivists. The fact that tight glycemic control is not only important for diabetics but also for nondiabetics is agreed upon by 51.7% of the responders.
Discussion
Hyperglycemia is a common occurrence in critical illness and previously used to be dismissed as stress hyperglycemia. While the diabetics who present with this problem are treated, many times the nondiabetics are not considered for treatment. Van Den Berghe et al. have shown clearly that normalization of blood sugars in critically ill patients in the surgical ICU with insulin infusion regimens signifi cantly reduces morbidity and mortality. [1] The recent paper by the same author has looked into the same scenario in the medical ICU. This study has again shown that irrespective of their previous diabetic status, all critically ill patients benefi ted from intensive insulin regimen in terms of morbidity benefi ts. It was shown that the in hospital stay and ICU stay were reduced, weaning from the ventilator was quicker and onset of new organ damage was also lesser. [2] In both the studies of intensive insulin infusion by Van den Berghe et al., the target sugar level was set at 110 mg/dL. This level has shown to provide signifi cant benefi ts.
Whether the high glucose level is the toxic agent and its control gives the benefi t or whether insulin with its anabolic effects is the protective agent is a point of constant debate. In one study by Finney et al., it was shown that increased insulin administration was associated with increased mortality irrespective of the sugar levels. Thus the study concluded that control of the sugar levels was the protective factor rather than the insulin dose administered. This study also suggested that the upper limit for glucose is 145 mg/dL below which mortality benefi ts increased. [3] There are several hypotheses to explain the protective effect of tight glycemic control in the critically ill with insulin infusion protocol. One hypothesis proposes that immune dysfunction is prevented by preventing hyperglycemia. [4] The intensive insulin infusion protocol is said to have an antiinfl ammatory action on the system which is said to provide morbidity and mortality benefi t. [5] There is one hypothesis which argues that intensive insulin therapy protects against endothelial damage. [6, 7] The insulin infusion is also said to protect the mitochondrial ultrastructure and function. [8] In another study conducted by Mesotten et al., it was shown that restoration of serum lipid profi le abnormalities signifi cantly contributed to the mortality benefi ts in patients on intensive insulin therapy during critical illness. [9] With this scenario in the background we assessed the KAP among the endocrinologists and intensivists about tight glycemic control in the critically ill. From this study it was observed that there was an overall consensus among the endocrinologists and the intensivists that tight glycemic control is essential in the critically ill. They also had a sound understanding of the reasons for using tight glycemic control and its benefi ts. There was a good awareness about the complications of this process of tight glycemic control. The endocrinologists and the intensivists also agreed on the fact that irrespective of their diabetic status all critically ill patients required intensive insulin therapy for achieving this target. The main points of disagreement were in the methodology of glucose monitoring and the type of insulin regime once the patients were shifted to the fl oors.
The probable reason for this good understanding and standard practices among the endocrinologists and intensivists is the immense popularity of the Van den Berghe articles and its frequent discussion in several forums. Also noteworthy is the high prevalence of diabetes in India and a general interest among the physicians about diabetes and glycemia-related issues. Further, critical care as a separate specialty is now evolving in our country and the physicians involved in it are keeping themselves updated in the recent developments. The methodological differences are more practical in nature, which is bound to happen in the milieu of wide differences in hospital policies and practices. The authors conclude that meetings among endocrinologists and intensivists and setting up of standard ICU glycemic control protocols will make the practices more uniform.
